Poggetto John Dal - Net Worth and Insider Trading

Poggetto John Dal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Poggetto John Dal owns 1 companies in total, including Sonoma Pharmaceuticals Inc (SNOA) .

Click here to see the complete history of Poggetto John Dal’s form 4 insider trades.

Insider Ownership Summary of Poggetto John Dal

Ticker Comapny Transaction Date Type of Owner
SNOA Sonoma Pharmaceuticals Inc 2019-09-27 Chief Financial Officer

Poggetto John Dal Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Poggetto John Dal Ownership Network

Ownership Network List of Poggetto John Dal

No Data

Ownership Network Relation of Poggetto John Dal


Poggetto John Dal Owned Company Details

What does Sonoma Pharmaceuticals Inc do?

Who are the key executives at Sonoma Pharmaceuticals Inc?

Poggetto John Dal is the Chief Financial Officer of Sonoma Pharmaceuticals Inc. Other key executives at Sonoma Pharmaceuticals Inc include Interim CFO Chad Norman White , Chief Financial Officer Jerome J Dvonch , and Chief Financial Officer Robert Grant Edwards .

Sonoma Pharmaceuticals Inc (SNOA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sonoma Pharmaceuticals Inc (SNOA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonoma Pharmaceuticals Inc (SNOA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sonoma Pharmaceuticals Inc (SNOA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sonoma Pharmaceuticals Inc Insider Transactions

No Available Data

Poggetto John Dal Mailing Address

Above is the net worth, insider trading, and ownership report for Poggetto John Dal. You might contact Poggetto John Dal via mailing address: 1129 N. Mcdowell Blvd, Petaluma Ca 94954.

Discussions on Poggetto John Dal

No discussions yet.